• Nomogram, Gastric Cancer
  • West Nile Virus (WNV) Antibody, IgG
  • Coxsackie A Virus Antibodies, CSF
  • HLA Class II DR, DQ and DP Genotyping (HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1)
  • Giardia Species by PCR, Stool
  • Malignant neoplasm of thymus
  • Acylphosphatase 2 (ACYP2) Genotyping
  • Hereditary Angioedema Diagnostic Panel
  • Hepatitis B Surface Antigen (HBsAg), Qualitative or Quantitative
  • Polyoma BK Virus, PCR, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment
Medical Test

Overview
Access to OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment is restricted.